M
Monteris Medical
A medical device venture developing new technologies for the treatment of cancer
About Monteris Medical
Monteris Medical is a pioneering medical technology company specializing in minimally invasive brain surgery solutions. The company's flagship product, NeuroBlate, is a laser ablation system designed to treat neurological lesions, including brain tumors and epileptic foci, with precision and minimal invasiveness. NeuroBlate integrates advanced software, disposables, and hardware to provide a comprehensive solution for healthcare professionals. Monteris Medical operates in the healthcare sector, primarily serving neurosurgeons and their patients. The company generates revenue through the sale of its NeuroBlate system and associated disposables, as well as through ongoing clinical trials and research initiatives. Monteris Medical's market includes hospitals, medical centers, and specialized neurosurgery clinics. The business model focuses on providing cutting-edge technology that improves patient outcomes while reducing the risks associated with traditional open neurosurgical procedures. The company's innovative approach and commitment to advancing medical technology position it as a leader in the field of minimally invasive neurosurgery.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1999
- Headquarters
- Minnetonka, United States
- Employees
- 128
- Open positions
- 3
- Dealroom signal
- 52.8/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Intellectual Property, Oncology, Surgery, Neurology, Non-Invasive medical devices and treatments, Spinout, Surgical Equipment, Tech for Medical Professionals, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Mar 2026 | $28M | $175M | Undisclosed | ↗ |
| DEBTDebt | Mar 2026 | $35M | — | Trinity Capital | ↗ |
Growth signals
Latest recorded traffic for Monteris Medical is 3.8K monthly website visits, up 8.6% over the last three months. Monteris Medical's team grew 6.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series B and later9 investors entered at this stage
Valhalla Private Capital
Oxford Finance
Southwest Michigan First Life Science Fund
SightLine Partners
Versant Ventures
Madryn Asset Management
InnovaHealth Partners
Birchview Capital
Trinity Capital
Other known investors1 additional known investor
University of Manitoba
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Monteris Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Monteris Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.